Lupin wins ruling on Vertex cystic fibrosis patents
A ruling has gone in favor of Lupin regarding Vertex patents related to a cystic fibrosis drug, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.